D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.76% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
IMAX
IMAX
$2.59B
| $3.48M | ﹤0.01% |
231,484
+109,959
| +90% | +$1.88M |
|
2077
nVent Electric
NVT
$22.9B
| $3.48M | ﹤0.01% |
58,838
-24,218
| -29% | -$1.28M |
|
2078
National Beverage
FIZZ
$3.05B
| $3.48M | ﹤0.01% |
69,925
+14,329
| +26% | +$686K |
|
|
AAMI
2079
Acadian Asset Management
AAMI
$2.94B
| $3.47M | ﹤0.01% |
181,122
+75,543
| +72% | +$1.33M |
|
2080
Southern Copper
SCCO
$140B
| $3.47M | ﹤0.01% |
43,438
-143,738
| -77% | -$10M |
|
2081
Archer Aviation
ACHR
$3.68B
| $3.46M | ﹤0.01% |
+563,935
| New | +$3.2M |
|
2082
Trip.com Group
TCOM
$28.5B
| $3.46M | ﹤0.01% |
96,125
-535,945
| -85% | -$18.3M |
|
|
WIRE
2083
CALL
DELISTED
Encore Wire Corp
WIRE
| $3.46M | ﹤0.01% |
16,200
-3,900
| -19% | -$743K |
|
2084
BrightView Holdings
BV
$1.3B
| $3.45M | ﹤0.01% |
410,299
+64,702
| +19% | +$493K |
|
|
FITB
2085
PUT
Fifth Third Bancorp
FITB
$52.4B
| $3.45M | ﹤0.01% |
100,000
| – | – |
|
2086
Navient
NAVI
$822M
| $3.45M | ﹤0.01% |
185,112
-100,010
| -35% | -$1.74M |
|
2087
Medifast
MED
$108M
| $3.44M | ﹤0.01% |
51,238
+389
| +0.8% | +$27.1K |
|
2088
Sociedad Química y Minera de Chile
SQM
$19.1B
| $3.44M | ﹤0.01% |
57,165
-7,715
| -12% | -$408K |
|
2089
Coherent
COHR
$47.6B
| $3.44M | ﹤0.01% |
79,041
-264,976
| -77% | -$9.55M |
|
2090
Sun Life Financial
SLF
$46.6B
| $3.44M | ﹤0.01% |
66,354
-112,717
| -63% | -$5.55M |
|
2091
Arlo Technologies
ARLO
$1.55B
| $3.44M | ﹤0.01% |
361,334
-129,013
| -26% | -$1.18M |
|
2092
PUT
Robinhood
HOOD
$83.3B
| $3.44M | ﹤0.01% |
+270,000
| New | +$2.68M |
|
2093
Goosehead Insurance
GSHD
$1.63B
| $3.44M | ﹤0.01% |
45,377
+26,685
| +143% | +$1.93M |
|
2094
PUT
Organon & Co
OGN
$3.55B
| $3.44M | ﹤0.01% |
+238,400
| New | +$3.24M |
|
2095
AnaptysBio
ANAB
$1.54B
| $3.43M | ﹤0.01% |
160,326
+14,434
| +10% | +$249K |
|
|
TRUE
2096
DELISTED
TrueCar
TRUE
| $3.43M | ﹤0.01% |
992,460
-62,537
| -6% | -$159K |
|
2097
Manulife Financial
MFC
$74.2B
| $3.43M | ﹤0.01% |
155,140
-92,000
| -37% | -$1.77M |
|
2098
Voyager Therapeutics
VYGR
$184M
| $3.43M | ﹤0.01% |
406,044
-220,079
| -35% | -$1.6M |
|
2099
CALL
Symbotic
SYM
$5.39B
| $3.41M | ﹤0.01% |
+66,400
| New | +$2.91M |
|
2100
CALL
Rio Tinto
RIO
$149B
| $3.4M | ﹤0.01% |
45,700
-288,900
| -86% | -$19.4M |
|
Similar funds
D.E. Shaw & Co's Q4 2023 Portfolio in Review
As of Q4 2023, D.E. Shaw & Co held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- D.E. Shaw & Co added most to Netflix in Q4 2023, an estimated $751M increase.
- D.E. Shaw & Co's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- D.E. Shaw & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- D.E. Shaw & Co opened 575 new positions and closed 527 in Q4 2023.
- D.E. Shaw & Co's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.